A Phase 1b/2a, Study Evaluating the Safety, PK/PD and Efficacy of NS101 in Healthy Volunteers and SSNHL Patients

NCT06249919 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

138

Enrollment

INDUSTRY

Sponsor class

Conditions

Seneorineural Deafness
Sudden Sensorineural Hearing Loss

Interventions

BIOLOGICAL: NS101
BIOLOGICAL: Placebo

Sponsor

Neuracle Science Co., LTD.

Collaborators

[object Object]
[object Object]
[object Object]